Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Wilkinson

Showing results (151-160 of 190) with videos related to

Pageof 19
Sort By:
Circulation|December 1, 1977
Suppression of ventricular ectopic depolarizations by tocainideR L Woosley, D G McDevitt, A S Nies, et al.
The Journal of Biological Chemistry|July 25, 1985
Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolismL M Distlerath, P E Reilly, M V Martin, et al.
Pharmacogenetics|December 11, 1999
Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the worldH G Xie, C M Stein, R B Kim, et al.
Clinical Pharmacology and Therapeutics|October 1, 1985
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsK Nakamura, F Goto, W A Ray, et al.
Clinical Pharmacology and Therapeutics|February 1, 1978
Biological determinants of propranolol disposition in manD M Kornhauser, A J Wood, R E Vestal, et al.
Clinical Pharmacology and Therapeutics|March 1, 1986
Co-inheritance of the polymorphic metabolism of encainide and debrisoquinR L Woosley, D M Roden, G H Dai, et al.
Cancer Research|January 1, 1984
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patientsK R Hande, P J Wedlund, R M Noone, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humansJ H Schellens, H Ghabrial, H H van der Wart, et al.
Pharmacogenetics|August 1, 1994
Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancerC M Fleming, R Persad, A Kaisary, et al.
The American Journal of Clinical Nutrition|June 1, 1979
Effect of acute alcohol ingestion on plasma pyridoxal 5'-phosphateT H Parker, J P Marshall, R K Roberts, et al.
Pageof 19

Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Circulation|December 1, 1977
Suppression of ventricular ectopic depolarizations by tocainideR L Woosley, D G McDevitt, A S Nies, et al.
The Journal of Biological Chemistry|July 25, 1985
Purification and characterization of the human liver cytochromes P-450 involved in debrisoquine 4-hydroxylation and phenacetin O-deethylation, two prototypes for genetic polymorphism in oxidative drug metabolismL M Distlerath, P E Reilly, M V Martin, et al.
Pharmacogenetics|December 11, 1999
Allelic, genotypic and phenotypic distributions of S-mephenytoin 4'-hydroxylase (CYP2C19) in healthy Caucasian populations of European descent throughout the worldH G Xie, C M Stein, R B Kim, et al.
Clinical Pharmacology and Therapeutics|October 1, 1985
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populationsK Nakamura, F Goto, W A Ray, et al.
Clinical Pharmacology and Therapeutics|February 1, 1978
Biological determinants of propranolol disposition in manD M Kornhauser, A J Wood, R E Vestal, et al.
Clinical Pharmacology and Therapeutics|March 1, 1986
Co-inheritance of the polymorphic metabolism of encainide and debrisoquinR L Woosley, D M Roden, G H Dai, et al.
Cancer Research|January 1, 1984
Pharmacokinetics of high-dose etoposide (VP-16-213) administered to cancer patientsK R Hande, P J Wedlund, R M Noone, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Differential effects of quinidine on the disposition of nifedipine, sparteine, and mephenytoin in humansJ H Schellens, H Ghabrial, H H van der Wart, et al.
Pharmacogenetics|August 1, 1994
Low activity of dapsone N-hydroxylation as a susceptibility risk factor in aggressive bladder cancerC M Fleming, R Persad, A Kaisary, et al.
The American Journal of Clinical Nutrition|June 1, 1979
Effect of acute alcohol ingestion on plasma pyridoxal 5'-phosphateT H Parker, J P Marshall, R K Roberts, et al.
Pageof 19